Anti-USP22 antibody (50-150) (STJ118728)
SPECIFICATIONS
ClonalityPolyclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG
General Information
| Short Description | Rabbit polyclonal USP22 (50-150) antibody for use in WB and ELISA in human and rat samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | WB/ELISA |
| Host | Rabbit |
| Reactivity | Human/Rat |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugation | Unconjugated |
| Concentration | Lot specific |
| Purification | Affinity purification |
| Dilution Range | WB:1:500-1:2000ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
| Formulation | PBS with 0.01% Thimerosal, 50% Glycerol, pH 7.3. |
| Storage Instruction | Store at-20ยฐC for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Target Information
| Gene Symbol | USP22 |
| Gene ID | 23326 |
| Uniprot ID | UBP22_HUMAN |
| Immunogen Region | 50-150 |
| Immunogen Sequence | TAEARKRKAKSCICHVCGVH LNRLHSCLYCVFFGCFTKKH IHEHAKAKRHNLAIDLMYGG IYCFLCQDYIYDKDMEIIAK EEQRKAWKMQGVGEKFSTWE P |
| Specificity | A synthetic peptide corresponding to a sequence within amino acids 50-150 of human USP22 (NP_056091.1). |
Additional Info
| Tissue Specificity | Moderately expressed in various tissues including heart and skeletal muscle, and weakly expressed in lung and liver. |
| Post Translational Modifications | Phosphorylated in G2/M phase, but not in G1 phase by CDK1. Ubiquitinated and subsequently degraded in a CDC20-dependent manner. |
| Function | Deubiquitinase that plays a role in several cellular processes including transcriptional regulation, cell cycle progression or innate immunity. As part of the transcription regulatory histone acetylation (HAT) complex SAGA, catalyzes the deubiquitination of both histones H2A and H2B, thereby acting as a transcriptional coactivator. Recruited to specific gene promoters by activators such as MYC, where it is required for transcription. Facilitates cell-cycle progression by stabilizing CCNB1 and antagonizing its proteasome-mediated degradation in a cell cycle-specific manner. Modulates cell cycle progression and apoptosis also by antagonizing TP53 transcriptional activation through deacetylase SIRT1 stabilization. Plays multiple roles in immunity and inflammation. Participates in antiviral response by deubiquitinating the importin KPNA2, leading to IRF3 nuclear translocation and subsequent type I interferon production. Acts as a central regulator of type III IFN signaling by negatively regulating STING1 activation and ubiquitination. Inhibits NLRP3 inflammasome activation by promoting NLRP3 degradation through ATG5-dependent autophagy. Deubiquitinates CD274 to induce its stabilization and thereby participates in maintenance of immune tolerance to self. Controls necroptotic cell death by regulating RIPK3 phosphorylation and ubiquitination. During bacterial infection, promotes pro-inflammatory response by targeting TRAF6 and removing its 'Lys-48'-linked polyubiquitination. |
| Protein Name | Ubiquitin Carboxyl-Terminal Hydrolase 22Deubiquitinating Enzyme 22Ubiquitin Thioesterase 22Ubiquitin-Specific-Processing Protease 22 |
| Database Links | Reactome: R-HSA-3214847Reactome: R-HSA-5689880 |
| Cellular Localisation | NucleusCytoplasm |
| Alternative Antibody Names | Anti-Ubiquitin Carboxyl-Terminal Hydrolase 22 antibodyAnti-Deubiquitinating Enzyme 22 antibodyAnti-Ubiquitin Thioesterase 22 antibodyAnti-Ubiquitin-Specific-Processing Protease 22 antibodyAnti-USP22 antibodyAnti-KIAA1063 antibodyAnti-USP3L antibody |
Information sourced from Uniprot.org